1-11 of 11
Anthony H. Barnett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment With the Dipeptidyl Peptidase-4 Inhibitor Linagliptin or Placebo Followed by Glimepiride in Patients With Type 2 Diabetes With Moderate to Severe Renal Impairment: A 52-Week, Randomized, Double-Blind Clinical Trial

Markku Laakso, Julio Rosenstock, Per-Henrik Groop, Anthony H. Barnett, Baptist Gallwitz, Uwe Hehnke, Ilkka Tamminen, Sanjay Patel, Maximilian von Eynatten, Hans-Juergen Woerle
Journal: Diabetes Care
Diabetes Care 2015;38(2):e15–e17
https://doi.org/10.2337/dc14-1684
Published: 10 January 2015
View article titled, Treatment With the Dipeptidyl Peptidase-4 Inhibitor Linagliptin or Placebo Followed by Glimepiride in Patients With Type 2 Diabetes With Moderate to Severe Renal Impairment: A 52-Week, Randomized, Double-Blind Clinical Trial
Open the PDF for Treatment With the Dipeptidyl Peptidase-4 Inhibitor Linagliptin or Placebo Followed by Glimepiride in Patients With Type 2 Diabetes With Moderate to Severe Renal Impairment: A 52-Week, Randomized, Double-Blind Clinical Trial in another window
Journal Articles

Elevated Serum Free Light Chains Predict Cardiovascular Events in Type 2 Diabetes

Srikanth Bellary, Jeffrey M. Faint, Lakhvir K. Assi, Colin A. Hutchison, Stephen J. Harding, Neil T. Raymond, Anthony H. Barnett
Journal: Diabetes Care
Diabetes Care 2014;37(7):2028–2030
https://doi.org/10.2337/dc13-2227
Published: 12 June 2014
View article titled, Elevated Serum Free Light Chains Predict Cardiovascular Events in Type 2 Diabetes
Open the PDF for Elevated Serum Free Light Chains Predict Cardiovascular Events in Type 2 Diabetes in another window
Journal Articles

Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study

Lamiae Grimaldi-Bensouda, David Cameron, Michel Marty, Anthony H. Barnett, Frédérique Penault-Llorca, Michael Pollak, Bernard Charbonnel, Matthew Riddle, Laurent Mignot, Jean-François Boivin, Artak Khachatryan, Michel Rossignol, Jacques Bénichou, Annick Alpérovitch, Lucien Abenhaim, for the ISICA Group
Journal: Diabetes Care
Diabetes Care 2014;37(1):134–143
https://doi.org/10.2337/dc13-0695
Published: 11 December 2013
View article titled, Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study
Open the PDF for Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study in another window
Includes: Supplementary data
Journal Articles

Obstructive Sleep Apnea and Diabetic Nephropathy: A cohort study

Abd A. Tahrani, PHD, Asad Ali, MRCP, Neil T. Raymond, MSC, Safia Begum, Kiran Dubb, MSC, Quratul-ain Altaf, MRCP, Milan K. Piya, MRCP, Anthony H. Barnett, MD, Martin J. Stevens, MD
Journal: Diabetes Care
Diabetes Care 2013;36(11):3718–3725
https://doi.org/10.2337/dc13-0450
Published: 15 October 2013
View article titled, Obstructive Sleep Apnea and Diabetic Nephropathy: <subtitle>A cohort study</subtitle>
Open the PDF for Obstructive Sleep Apnea and Diabetic Nephropathy: <subtitle>A cohort study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Higher Prevalence of Retinopathy in Diabetic Patients of South Asian Ethnicity Compared With White Europeans in the Community: A cross-sectional study

Neil T. Raymond, MSC, Lakshminarayanan Varadhan, MRCP, Dilini R. Reynold, MD, Kate Bush, BM, Sailesh Sankaranarayanan, MRCP, Srikanth Bellary, MRCP, Anthony H. Barnett, FRCP, Sudhesh Kumar, FRCP, J. Paul O'Hare, FRCP, on behalf of the UK Asian Diabetes Study Retinopathy Study Group
Journal: Diabetes Care
Diabetes Care 2009;32(3):410–415
https://doi.org/10.2337/dc08-1422
Published: 01 March 2009
View article titled, Higher Prevalence of Retinopathy in Diabetic Patients of South Asian Ethnicity Compared With White Europeans in the Community: <subtitle>A cross-sectional study</subtitle>
Open the PDF for Higher Prevalence of Retinopathy in Diabetic Patients of South Asian Ethnicity Compared With White Europeans in the Community: <subtitle>A cross-sectional study</subtitle> in another window
Journal Articles

Latent Autoimmune Diabetes in Adults in a South Asian Population of the U.K.

Abigail C. Britten, BSC, Karen Jones, BSC, Carina Törn, PHD, Magnus Hillman, PHD, Birgitte Ekholm, Sudhesh Kumar, MD, FRCP, Anthony H. Barnett, MD, FRCP, Marilyn Ann Kelly, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(12):3088–3090
https://doi.org/10.2337/dc07-0896
Published: 01 December 2007
View article titled, Latent Autoimmune Diabetes in Adults in a South Asian Population of the U.K.
Open the PDF for Latent Autoimmune Diabetes in Adults in a South Asian Population of the U.K. in another window
Journal Articles

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin: Response to Kanna and Abreu-Pacheco

Anthony H. Barnett, BSC, MD, FRCP, Manfred Dreyer, MD, Peter Lange, MD, Marjana Serdarevic-Pehar, on behalf of the Exubera Phase III Study Group
Journal: Diabetes Care
Diabetes Care 2007;30(2):446
https://doi.org/10.2337/dc06-2173
Published: 01 February 2007
View article titled, An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin: <subtitle>Response to Kanna and Abreu-Pacheco</subtitle>
Open the PDF for An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin: <subtitle>Response to Kanna and Abreu-Pacheco</subtitle> in another window
Journal Articles

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Meformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea: Response to Mikhail and Cope

Anthony H. Barnett, BSC, MD, FRCP, Manfred Dreyer, MD, Peter Lange, MD, Marjana Serdarevic-Pehar, on behalf of the Exubera Phase III Study Group
Journal: Diabetes Care
Diabetes Care 2006;29(10):2333–2334
https://doi.org/10.2337/dc-06-1466
Published: 01 October 2006
View article titled, An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Meformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea: <subtitle>Response to Mikhail and Cope</subtitle>
Open the PDF for An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Meformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea: <subtitle>Response to Mikhail and Cope</subtitle> in another window
Journal Articles

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin

Anthony H. Barnett, BSC, MD, FRCP, Manfred Dreyer, MD, Peter Lange, MD, Marjana Serdarevic-Pehar, MD, on behalf of the Exubera Phase III Study Group
Journal: Diabetes Care
Diabetes Care 2006;29(8):1818–1825
https://doi.org/10.2337/dc05-1880
Published: 01 August 2006
View article titled, An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin
Open the PDF for An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Glibenclamide as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on Metformin in another window
Journal Articles

An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Metformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea

Anthony H. Barnett, BSC, MD, FRCP, Manfred Dreyer, MD, Peter Lange, MD, Marjana Serdarevic-Pehar, on behalf of the Exubera Phase III Study Group
Journal: Diabetes Care
Diabetes Care 2006;29(6):1282–1287
https://doi.org/10.2337/dc05-1879
Published: 01 June 2006
View article titled, An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Metformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea
Open the PDF for An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Metformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea in another window
Journal Articles

Familial Early-Onset Type 2 Diabetes in Chinese Patients: Obesity and genetics have more significant roles than autoimmunity

Maggie C.Y. Ng, PHD, Shao-Chin Lee, PHD, Gary T.C. Ko, FRCP, June K.Y. Li, MRCP, Wing-Yee So, MRCP, Yasmeen Hashim, PHD, Anthony H. Barnett, MD, Ian R. Mackay, MD, Julian A.J.H. Critchley, FRCP, Clive S. Cockram, FRCP, Juliana C.N. Chan, FRCP
Journal: Diabetes Care
Diabetes Care 2001;24(4):663–671
https://doi.org/10.2337/diacare.24.4.663
Published: 01 April 2001
View article titled, Familial Early-Onset Type 2 Diabetes in Chinese Patients: <subtitle>Obesity and genetics have more significant roles than autoimmunity</subtitle>
Open the PDF for Familial Early-Onset Type 2 Diabetes in Chinese Patients: <subtitle>Obesity and genetics have more significant roles than autoimmunity</subtitle> in another window